2021

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications, Expert review of pharmacoeconomics & outcomes research, 1-14 Vol 4

Doctors’ views and strategies to improve patients’ adherence to medication, Hormones, 1-9

Variation in the prices of oncology medicines across Europe and the implications for the future, Generics and Biosimilars Initiative journal 10 (2), 72-82

Greek cardiologists' interventions to manage patients' adherence, Hellenic Journal of Cardiology: HJC

Quo Vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges, Frontiers in public health 8, 994

2020

Τhe economic crisis, the memorandum and the reforms in the Health System of Cyprus, Archives of Hellenic Medicine 37 (6), 832-843

Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications, The European Journal of Health Economics 21 (5), 729-743 3

Patients’ and doctors’ beliefs about treatment and long-term adherence in rheumatic diseases
Mediterranean Journal of Rheumatology 31 (Suppl 1), 152 2

Awaiting the “catharsis”, The European Journal of Health Economics, 1-6 2

2019

Cluster shifts based on healthcare factors: The case of Greece in an OECD background 2009-2014, Advances in Management and Applied Economics 9 (6), 29-50

Pricing of oral generic cancer medicines in 25 European countries; findings and implications, Generics and Biosimilars Initiative Journal 8 (2), 49-70 35

Cost containment and health expenditure in the EU: A Macroeconomic Perspective
Health Care and Cost Containment in the European Union, 155-196 14

Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA, Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261 25

Proposal for a Regulation on Health Technology Assessment in Europe-opinions of policy makers, payers and academics from the field of HTA

2018

Barriers for access to new medicines: searching for the balance between rising costs and limited budgets, Frontiers in public health 6, 328 83

Income-related health inequalities among the migrant and native-born populations in Greece during the economic crisis: a decomposition analysis, European journal of public health 28 (suppl_5), 24-31 6

Drug policy in Greece, Value in health regional issues 16, 66-73 13 2018

Financial protection of households against health shocks in Greece during the economic crisis, Social Science & Medicine 211, 338-351 21 2018

Barriers for Access to New Medicines: searching for the Balance Between Rising Costs and Limited Budgets

2017

PRM211: Changes In Private Financing Of The Greek Health System During The Economic Crisis
Conference abstract Value in Health, Volume 20, Issue 9, October–November 2017,

PHS99: Unmet Pharmaceutical Needs During The Economic Crisis In Greece
Conference abstract: Value in Health, Volume 20, Issue 9, October–November 2017,

PHS100: The Effects Of The Economic Crisis On Health Status And Health Inequalities In Greece
Conference abstract: Value in Health, Volume 20, Issue 9, October–November 2017,

PHS92: Cost Containment And Privatisation Of Pharmaceutical Care In Greece: A Review Of Policy Reforms Under The Memorandums’ Requirements
Conference abstract Value in Health, Volume 20, Issue 9,October–November 2017,

PRM192: Cost-Effectiveness Analysis Of Insulin Degludec U100 Compared With Insulin Glargine U100 In Greece
Conference abstract: Value in Health, Volume 20, Issue 9, October–November 2017,

2016

PHS80: The Impact of Psoriasis Vulgaris on Health-Related Quality of Life In Greece
Conference abstract Value in Health, Volume 19, Issue 7, November 2016,

PHS161: Determinants of The Impact of The Economic Crisis on General and Oral Health in Greater Athens Area Greece
Conference abstract: Value in Health, Volume 19, Issue 7, November 2016,

PHS103: Oral And General Health-Related Quality of Life In Times of Crisis In Greece
Conference abstract:  Value in Health, Volume 19, Issue 7, November 2016,

PHS125: THE IMPACT OF THE ECONOMIC CRISIS ON THE INCIDENCE AND INTENSITY OF CATASTROPHIC HEALTH PAYMENTS IN GREECE
Conference abstract: Value in Health, Volume 19, Issue 7, November 2016,

PHS78: The EQ-5D-5L Instrument Demonstrates Better Performance Compared With The EQ-5D-3L In Psoriatic Patients
Conference abstract: Value in Health, Volume 19, Issue 7, November 2016,

PDB81: The Incidence of Hypoglycemia in Type II Diabetes Mellitus (T2DM) Patients Treated with Insulin Therapy in Combination with DPP-4 in Greece. A Sub-Analysis of Hypo 2 Study
Conference abstract: Value in Health, Volume 19, Issue 7, November 2016

PDB82: The Influence of Glycemic Control in the Quality of Life of Type 2 Diabetes Mellitus Patients in Greece-the Hypo2 Study
Conference abstract: Value in Health, Volume 19, Issue 7, November 2016,

2014

PDB137: The Prevalence of Hypoglycemia and Its Impact on The Quality of Life of Type 2 Diabetes Mellitus Patients in Greece (The Hypo Study)
Conference abstract: Value in Health, Volume 17, Issue 7, November 2014,

PDB141: Association of Hypoglycemia With Different Oral Antidiabetic Treatments and Its Impact on Quality of Life and Disease Control In Patients With Type 2 Diabetes Mellitus (The Hypo Study)
Conference abstract: Value in Health, Volume 17, Issue 7, November 2014,

PSS4: Outcomes of Patients With Neovascular Age-Related Macular Degeneration (Named) In Greece Under Ranibizumab
Conference abstract Value in Health, Volume 17, Issue 7, November 2014,

2012

PSY44 A Cost-Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care Regimens
Conference abstract: Value in Health, Volume 15, Issue 7, November 2012, Page a516

PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Greece: One Move Forward to Efficiency
Conference abstract: Value in Health, Volume 15, Issue 7, November 2012,

PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C: A Greek National Health System Perspective
Conference abstract: Value in Health, Volume 15, Issue 7, November 2012,

PDB43 Economic Evaluation of Vildagliptin Compared to Glimepiride as Add-on to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece
Conference abstract: Value in Health, Volume 15, Issue 7, November 2012,

2011

PMS68 Measuring the Health-Related Quality of Life in Patients with Rheumatoid Arthritis Treated with Adalimumab in Greece: Comparing the Results of One Generic (EQ-5D) and One Disease-Specific (HAQ) Instrument
Conference abstract: Value in Health, Volume 14, Issue 7, November 2011,

PCV83 A Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome in Greece
Conference abstract  Value in Health, Volume 14, Issue 7, November 2011,

PHP40 HEALTH CARE REFORMS UNDER ECONOMIC CRISIS: THE GREEK CASE
Conference abstract: Value in Health, Volume 14, Issue 3, May 2011,

PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in Greece
Conference abstract: Value in Health, Volume 14, Issue 7, November 2011,

PMS76 A LONGITUDINAL COMPARISON OF MAPPING EQUATIONS DERIVED FROM BASELINE AND POST-INTERVENTION DATA
Conference abstract: Value in Health, Volume 13, Issue 7, November 2010,

PMS48 PSYCHOMETRIC PROPERTIES OF THE GREEK MODIFIED HEALTH ASSESSMENT QUESTIONNAIRE FOR ASSESSING PHYSICAL DISABILITY IN RHEUMATOID ARTHRITIS
Conference abstract: Value in Health, Volume 13, Issue 7, November 2010,

2007-2008

PCN17 ESTIMATING THE COST SAVINGS FROM THE INTRODUCTION OF KRAS TESTING IN THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING PANITUMUMAB IN GREECE
Conference abstract: Value in Health, Volume 11, Issue 6, November 2008,

PCN104 A BUDGET IMPACT MODEL FOR THE INTRODUCTION OF PANITUMUMAB, A NEW THERAPY FOR THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) IN GREECE
Conference abstract: Value in Health, Volume 11, Issue 6, November 2008,

PCV79 ECONOMIC EVALUATION OF IRBESARTAN IN GREECE
Conference abstract: Value in Health, Volume 11, Issue 6, November 2008,

PMS49 HEALTH-RELATED QUALITY OF LIFE (HRQL) OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS (RA) PATIENTS IN GREECE: PRELIMINARY RESULTS FROM THE HEOR STUDY
Conference abstract: Value in Health, Volume 11, Issue 6, November 2008,

PSU2/ES4 THE RELATIVE COST-EFFECTIVENESS OF THE FENTANYL HCL PATIENT-ACTIVATED TRANSDERMAL SYSTEM (ITS) IN ACUTE POST-OPERATIVE PAIN MANAGEMENT (POPM) IN GREECE
Conference abstract: Value in Health, Volume 10, Issue 6, November–December 2007,

2004

P.2.065 Does improvement in psychopathology correlate with improvement in health-related quality of life? Results from the SQUARE study
Conference abstract: European Neuropsychopharmacology, Volume 14, Supplement 3, October 2004,

PMH42 CORRELATIONS BETWEEN PSYCHOPATHOLOGY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) MEASURES IN SCHIZOPHRENIA. RESULTS FROM THE SQUARE STUDY
Conference abstract: Value in Health, Volume 7, Issue 3, May–June 2004,

PMH48 ASSESSMENT OF THE IMPACT OF QUETIAPINE TREATMENT ON PSYCHOPATHOLOGY, HEALTH-RELATED QUALITY OF LIFE AND DISABILITY IN PATIENTS WITH SCHIZOPHRENIA IN GREECE.THE SQUARE STUDY
Conference abstract: Value in Health, Volume 7, Issue 3, May–June 2004,

1999

PCP7: COSTS AND OUTCOMES OF REGIONAL VERSUS GENERAL VERSUS COMBINATION ANESTHESIA AND ANALGESIA TECHNIQUES IN GREEK PATIENTS UNDERGOING HIP ARTHROPLASTY
Conference abstract: Value in Health, Volume 2, Issue 3, May 1999,

PCP8: ASSESSMENT OF SURGICAL ANESTHESIA AND POSTOPERATIVE ANALGESIA USING A PAIN VISUAL ANALOG SCALE
Conference abstract: Value in Health, Volume 2, Issue 3, May 1999